Treatment of Crohn’s disease of inflammatory, stenotic, and fistulizing phenotypes

@article{Dubinsky2003TreatmentOC,
  title={Treatment of Crohn’s disease of inflammatory, stenotic, and fistulizing phenotypes},
  author={M. Dubinsky and P. Fleshner},
  journal={Current Treatment Options in Gastroenterology},
  year={2003},
  volume={6},
  pages={183-200}
}
  • M. Dubinsky, P. Fleshner
  • Published 2003
  • Medicine
  • Current Treatment Options in Gastroenterology
  • Opinion statementThe heterogeneous nature of Crohn’s disease (CD) is reflected in the diversity of treatment options available for individual patients. The stratification of CD patients into more homogeneous groups based on disease location and disease behavior may provide clinicians with a more focused approach to therapeutic decision-making. Uncomplicated disease behaviors are typically treated medically. When complications arise and patterns of disease become more aggressive, combined… CONTINUE READING
    4 Citations

    References

    SHOWING 1-10 OF 69 REFERENCES
    Long-Term Evolution of Disease Behavior of Crohn's Disease
    • 1,055
    Infliximab for the treatment of fistulas in patients with Crohn's disease.
    • 1,926
    • PDF
    Combination ciprofloxacin and metronidazole for active Crohn's disease.
    • 161
    • PDF
    Oral Budesonide for Active Crohn's Disease
    • 415